Insights-as-a-Service
Exclusively for Specialty and Rare Diseases
Specialty and rare diseases have undefined patient populations, with individuals who are undiagnosed or misdiagnosed, health care providers who are unaware of disease states and their manifestations, as well as treatment journeys that are not well understood.
DISEASE PREVALENCE
COMMON CONDITIONS:
High/Primary Care Focused
SPECIALTY/RARE DISEASE
Low/Specialty Care Focused
PATIENT IDENTIY
COMMON CONDITIONS:
Known and Diagnosed
SPECIALTY/RARE DISEASE
Unknown and Mis/Undiagnosed
PATIENT IDENTIY
PATIENT LIFETIME VALUE
COMMON CONDITIONS:
Low with Adherence Risks
SPECIALTY/RARE DISEASE
High with Critical Dependency
HCP ACTIVATION PATH
COMMON CONDITIONS:
Static/Programmatic Engagement
SPECIALTY/RARE DISEASE
Dynamic/1:1 Engagement
HCP ACTIVATION PATH
DATA AVAILABILITY
COMMON CONDITIONS:
Rx and/or ICD 10 Claims
SPECIALTY/RARE DISEASE
Multi-Source Unified RWD and RWE
ANALYTICS APPROACH
COMMON CONDITIONS:
Manual Data Wrangling & Analysis
SPECIALTY/RARE DISEASE
ML and AI-Driven Decision Science
ANALYTICS APPROACH
Market Assessment
Maximize commercialization efforts by forecasting market size, competitive landscape and potential ROI.
Patient Finding and Segmentation
Uncover ideal patients who are undiagnosed and/or misdiagnosed who may be appropriate for disease interception and therapeutic intervention.
Prevalence Estimation
Statistically model the number of disease cases present in a particular patient population at a given time.
KOL Discovery
Identify physicians who diagnose and treat ideal patients and influence other health care providers and patients as brand evangelists across their sphere of influence.
Epidemiological Evaluation
Identify the physical, biological, social, environmental, cultural and behavioral factors influencing health, and determine how widespread conditions appear in a particular patient population.
HCP Targeting and Segmentation
Identify and prioritize the health care providers relevant to your brand. Allocate resources for personal/non-personal promotion based on clinical and behavioral profiles. Segment to deliver relevant messaging and prioritize field activities using alerts.
Patient Profiling
Understand how social determinants of health (SDOH) factors can be used to better engage, educate and influence patients to improve their health outcomes.
Referral Network Mapping
Discover the movement of ideal patients among treating physicians, what connections exist between prescribers and which health care providers are treating the most patients relative to a therapy.
Patient Journey Mapping
Discover composition of care events and health care provider touchpoints toward successful disease interception, diagnosis and treatment.
Specialty Inference
Discover the archetype profile of each specialty. Determine to what extent health care providers “look" like their stated specialty or other specialties based on behavioral observations rather than self-reported data.
Our Smart Data Universe
We always begin with the precise business problem we are trying to solve prior to curating and unifying the right real world data streams for inclusion in our data universe. It's the very reason why we can optimize the design of our algorithms to uncover high-definition insights as well as achieve better performance results.
Health Claims
Integrated Affiliations
Social Determinants of Health
Clinical Stages
Health Claims
- 300M+ Unique Patient Journeys
- Over a decade of history with weekly updates across TAs
- First Party Input Data lab, trial, EHR, hub and more
Integrated Affiliations
- National HCO Coverage across 100% of hospitals, IDNs, systems and many more
- 95% Accuracy on account-level insights
- Referral Mapping network and affiliation patterns between providers and accounts
Social Determinants of Health
- 80% US Households
- 3,700+ consumer attributes
- 65 billion consumer records
Clinical Stages
- Integrated Global R&D Intelligence
- Historical and Active Trial Studies
- Principal Investigators mapped to NPI identifier
Health Claims
Health Claims
- 300M+ Unique Patient Journeys
- Over a decade of history with weekly updates across TAs
- First Party Input Data lab, trial, EHR, hub and more
Integrated Affiliations
Integrated Affiliations
- National HCO Coverage across 100% of hospitals, IDNs, systems and many more
- 95% Accuracy on account-level insights
- Referral Mapping network and affiliation patterns between providers and accounts
Social Determinants of Health
Social Determinants of Health
- 80% US Households
- 3,700+ consumer attributes
- 65 billion consumer records
Clinical Stages
Clinical Stages
- Integrated Global R&D Intelligence
- Historical and Active Trial Studies
- Principal Investigators mapped to NPI identifier
Health Claims
Integrated Affiliations
Social Determinants of Health
Clinical Stages
300M+ Unique Patient Journeys
Over a decade of history with weekly updates across TAs
First Party Input Data lab, trial, EHR, hub and more
National HCO Coverage across 100% of hospitals, IDNs, systems and many more
95% Accuracy on account-level insights
Referral Mapping network and affiliation patterns between providers and accounts
80% US Households
3,700+ consumer attributes
65 billion consumer records
Integrated Global R&D Intelligence
Historical and Active Trial Studies
Principal Investigators mapped to NPI identifier
Health Claims
300M+ Unique Patient Journeys
Over a decade of history with weekly updates across TAs
First Party Input Data lab, trial, EHR, hub and more
Integrated Affiliations
National HCO Coverage across 100% of hospitals, IDNs, systems and many more
95% Accuracy on account-level insights
Referral Mapping network and affiliation patterns between providers and accounts
Social Determinants of Health
80% US Households
3,700+ consumer attributes
65 billion consumer records
Clinical Stages
Integrated Global R&D Intelligence
Historical and Active Trial Studies
Principal Investigators mapped to NPI identifier
Specialty and Rare Disease Client Engagement
-
Neurology/Neuromuscular
Frontotemporal dementia (FTD)
X-Linked Myotubular Myopathy (XLMTM) Neuromuscular Genetic Disease
Archonodroplasia (Musculoskeletal condition)
Spinal Muscular Atrophy (SMA)
Hereditary ATTR (hATTR) amyloidosis
Adult Spasticity (AS) and Spasticity and Movement Disorders (SMD)
Cervical Dystonia (CD)
Amyotrophic Lateral Sclerosis (ALS)
Duchenne Muscular Dystrophy (DMD)
Multiple Sclerosis (MS)
Dementia Related Psychosis (DRP)
Infantile Spasm
-
Ophthalmology
balletic RPE65 mutaton-associated retinal dystrophy
-
Hematology/Oncology
Warm Autoimmune hemolytic anemia (wAIHA)
Idiopathic thrombocytopenia purpura (ITP)
Relapsed or Refractory Multiple Myeloma (rrMM)
Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL)
Relapsed/Refractory Diffuse Large B cell Lymphoma (DLBCL)
NSCLC ALK-mutated
Systemic Mastocytosis
Hairy Cell Leukemia (HCL)
Tenosynovial Giant Cell Tumor (TGCT)
Sickle Cell Disease (SCD)
Granulomatosis with polyangiitis (GPA) formerly called Wegerer's Granulomotosis
Mycosis Fungoides (MF)
Sezary Syndrome (SS)
Systemic Mastocytosis (SM)
Myleofibrosis
-
Genetic Diseases/Other
WHIM (warts, hypogammaglobulinemia, infections and myelokathexis) Syndrome
Fabry Disease
Fragile X Syndrome (FXS)
Acute Hepatic Porphyria (AHP)
Hypoactive Sexual Desire Disorder
PIK3CA-Related Overgrowth Spectrum (PROS)
Urea Cycle Disorder (UCD) specifically Ornithine Transcarbamylase Deficiency (OTCD)
Dravet's Syndrome
X-linked hypophosphatemia (XLH)
-
Respiratory
Non-Cystic Fibrosis Bronchiectasis (Respiratory Disease)
Hypertrophic Cardiomyopathy (HCM)
Pulmonary Arterial Hypertension (PAH) or PH
Nontuberculous Mycobacterial (NTM) Lung Disease (refractory)
Download Our Case Studies and Publications
Thank you for submitting this Form.